{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:08:07Z","timestamp":1792112887695,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.psychres.2019.112598","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T11:17:42Z","timestamp":1570101462000},"page":"112598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps"],"prefix":"10.1016","volume":"281","author":[{"given":"Jingjing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiodong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjun","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2019.112598_bib0001","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.279.1.23","article-title":"Fish consumption and risk of sudden cardiac death","volume":"279","author":"Albert","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2019.112598_bib0002","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s002130050010","article-title":"5-HT3- and 5-HT2C-antagonist properties of cyamemazine: significance for its clinical anxiolytic activity","volume":"147","author":"Alvarez-Guerra","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2019.112598_bib0003","first-page":"495","article-title":"Fifty years chlorpromazine: a historical perspective","volume":"3","author":"Ban","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2019.112598_bib0004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0269881112450778","article-title":"The response to sulpiride in social anxiety disorder: D2 receptor function","volume":"27","author":"Bell","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112598_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1152\/physrev.00008.2016","article-title":"Molecular pathophysiology of congenital long QT syndrome","volume":"97","author":"Bohnen","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0166-4328(01)00238-8","article-title":"Cyamemazine as an anxiolytic drug on the elevated plus maze and light\/dark paradigm in mice","volume":"124","author":"Bourin","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2019.112598_bib0007","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/L16-0353","article-title":"The accuracy of heart rate monitoring by some wrist-worn activity trackers","volume":"166","author":"Cadmus-Bertram","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/2013.jamainternmed.744","article-title":"Atrial fibrillation and the risk of sudden cardiac death the atherosclerosis risk in communities study and cardiovascular health study","volume":"173","author":"Chen","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0009","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2016.11.185","article-title":"Antipsychotic treatment is associated with risk of atrial fibrillation: a nationwide nested case-control study","volume":"227","author":"Chou","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.psychres.2019.112598_bib0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1152\/physrev.00005.2004","article-title":"Inherited and acquired vulnerability to ventricular arrhythmias: cardiac Na+ and k+ channels","volume":"85","author":"Clancy","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0011","first-page":"421","article-title":"Pimozide: use in Tourette's syndrome","volume":"19","author":"Colvin","year":"1985","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.psychres.2019.112598_bib0012","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1213\/00000539-199906000-00032","article-title":"Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis","volume":"88","author":"Domino","year":"1999","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.psychres.2019.112598_bib0013","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJM199304293281707","article-title":"Cardiac ion channels","volume":"328","author":"Epstein","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0014","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1517\/14656566.2013.819345","article-title":"Pimavanserin for the treatment of Parkinson's disease psychosis","volume":"14","author":"Friedman","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.psychres.2019.112598_bib0015","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.psychres.2019.112598_bib0016","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCGENETICS.113.000260","article-title":"Arrhythmia risk in long-QT syndrome: beyond the disease-causative mutation","volume":"6","author":"Giudicessi","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.psychres.2019.112598_bib0017","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2165\/00003495-200262110-00006","article-title":"Antipsychotic-related QTc prolongation, torsade de pointes and sudden death","volume":"62","author":"Haddad","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2019.112598_bib0018","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bmj.325.7372.1070","article-title":"Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data","volume":"325","author":"Hennessy","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2019.112598_bib0019","first-page":"21","article-title":"Pimavanserin: an inverse agonist antipsychotic drug","volume":"54","author":"Howland","year":"2016","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"key":"10.1016\/j.psychres.2019.112598_bib0020","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehv695","article-title":"The genetics underlying acquired long QT syndrome: impact for genetic screening","volume":"37","author":"Itoh","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.psychres.2019.112598_bib0021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.phrs.2017.10.007","article-title":"Atrial fibrillation and arterial hypertension","volume":"128","author":"Kallistratos","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2019.112598_bib0022","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2017.03.013","article-title":"Clozapine and incidence of myocarditis and sudden death - long term Australian experience","volume":"238","author":"Khan","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.psychres.2019.112598_bib0023","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(17)31072-3","article-title":"The future of atrial fibrillation management: integrated care and stratified therapy","volume":"390","author":"Kirchhof","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2019.112598_bib0024","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2018.02.073","article-title":"Smart watches for heart rate assessment in atrial arrhythmias","volume":"266","author":"Koshy","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.psychres.2019.112598_bib0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003088-199937060-00001","article-title":"Pharmacokinetics of haloperidol: an update","volume":"37","author":"Kudo","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.psychres.2019.112598_bib0026","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2019.112598_bib0027","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1213\/00000539-199411000-00028","article-title":"Droperidol causes a dose-dependent prolongation of the QT interval","volume":"79","author":"Lischke","year":"1994","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.psychres.2019.112598_bib0028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"Lopez-Munoz","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112598_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-013-9779-5","article-title":"Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives","volume":"37","author":"Mahida","year":"2013","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.psychres.2019.112598_bib0030","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/1470320315589272","article-title":"Blood pressure reduction and control with fixed-dose combination perindopril\/amlodipine: a Pan-Hellenic prospective observational study","volume":"16","author":"Manolis","year":"2015","journal-title":"J. Renin-Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.psychres.2019.112598_bib0031","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0195-668X(03)00479-2","volume":"24","author":"Maron","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.psychres.2019.112598_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/JCNSD.S4138","article-title":"Ziprasidone hydrocloride: what role in the management of schizophrenia?","volume":"3","author":"Mattei","year":"2011","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.psychres.2019.112598_bib0033","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1991.tb01421.x","article-title":"A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland","volume":"84","author":"Mehtonen","year":"1991","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2019.112598_bib0034","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1586\/14737175.7.7.829","article-title":"Cardiovascular effects of antipsychotics","volume":"7","author":"Michelsen","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.psychres.2019.112598_bib0035","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/B978-0-12-417197-8.00012-2","article-title":"Sodium channels, cardiac arrhythmia, and therapeutic strategy","volume":"70","author":"Miller","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.psychres.2019.112598_bib0036","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.psychres.2019.112598_bib0037","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","volume":"99","author":"O'Mahony","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.psychres.2019.112598_bib0038","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001040","article-title":"The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia","volume":"7","author":"Pani","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112598_bib0039","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/eurheartj\/ehi629","article-title":"TRACE Study Investigators Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation\/flutter following acute myocardial infarction","volume":"27","author":"Pedersen","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.psychres.2019.112598_bib0040","article-title":"Wearable technology for cardiology: an update and framework for the future","author":"Pevnick","year":"2017","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0041","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112598_bib0042","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pds.3346","article-title":"Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort","volume":"21","author":"Purhonen","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2019.112598_bib0043","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0044","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archpsyc.58.12.1161","article-title":"Antipsychotics and the risk of sudden cardiac death","volume":"58","author":"Ray","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112598_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.psychres.2019.112598_bib0046","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2019.112598_bib0047","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.180.6.515","article-title":"Thioridazine and sudden unexplained death in psychiatric in-patients","volume":"180","author":"Reilly","year":"2002","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2019.112598_bib0048","first-page":"761","article-title":"The antidepressant action of flupenthixol","volume":"225","author":"Robertson","year":"1981","journal-title":"Practitioner"},{"key":"10.1016\/j.psychres.2019.112598_bib0049","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1161\/CIR.0000000000000428","article-title":"Use of mobile devices, social media, and crowdsourcing as digital strategies to improve emergency cardiovascular care: a scientific statement from the American Heart Association","volume":"134","author":"Rumsfeld","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.psychres.2019.112598_bib0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2019.112598_bib0051","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/physrev.00022.2013","article-title":"Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia","volume":"94","author":"Schmitt","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009777","article-title":"Flupenthixol versus placebo for schizophrenia","volume":"11","author":"Shen","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0053","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15420\/aer.2018.29.2","article-title":"Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest","volume":"7","author":"Sicouri","year":"2018","journal-title":"Arrhythm. Electrophysiol. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0054","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.102.17.2137","article-title":"Enhanced Ca2+ release and Na\/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis","volume":"102","author":"Sipido","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.psychres.2019.112598_bib0055","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0056","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007779.pub2","article-title":"Levomepromazine for schizophrenia","author":"Sivaraman","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0057","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000166405.49473.70","article-title":"Antipsychotic drugs and QT prolongation","volume":"20","author":"Stollberger","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112598_bib0058","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/jce.12666","article-title":"IKs gain\u2010and loss\u2010of\u2010function in early\u2010onset lone atrial fibrillation","volume":"26","author":"Steffensen","year":"2015","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.psychres.2019.112598_bib0059","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.164.12.1293","article-title":"Antipsychotics and the risk of sudden cardiac death","volume":"164","author":"Straus","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.psychres.2019.112598_bib0060","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCULATIONAHA.116.023980","article-title":"Common genetic variant risk score is associated with drug-induced QT prolongation and torsade de pointes risk: a pilot study","volume":"135","author":"Strauss","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.psychres.2019.112598_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-5198(19)30621-3","article-title":"Drug-induced torsade de pointes: from molecular biology to bedside","volume":"83","author":"Tamargo","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.psychres.2019.112598_bib0062","first-page":"77","article-title":"Drugs, QT interval abnormalities and ventricular arrhythmias","volume":"13","author":"Thomas","year":"1994","journal-title":"Adverse Drug React. Toxicol. Rev."},{"key":"10.1016\/j.psychres.2019.112598_bib0063","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00004714-200112000-00023","article-title":"Clozapine and sudden death","volume":"21","author":"Tie","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2019.112598_bib0064","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(05)73083-X","article-title":"The heart of psychotropic drug therapy","volume":"355","author":"Tie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2019.112598_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154420","article-title":"Accuracy of heart rate watches: implications for weight management","volume":"11","author":"Wallen","year":"2016","journal-title":"PloS one"},{"key":"10.1016\/j.psychres.2019.112598_bib0066","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/jamacardio.2016.3340","article-title":"Accuracy of wrist-worn heart rate monitors","volume":"2","author":"Wang","year":"2017","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.psychres.2019.112598_bib0067","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001568","article-title":"Antipsychotic drugs and the risk of ventricular arrhythmia and\/or sudden cardiac death: a nation-wide case-crossover study","volume":"4","author":"Wu","year":"2015","journal-title":"J. Am. Heart Assoc."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119308364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178119308364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:39:08Z","timestamp":1759037948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178119308364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":67,"alternative-id":["S0165178119308364"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112598","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.112598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112598"}}